Yamaguchi, K.; Kawahara, T.; Hashizume, A.; Ousaka, K.; Uemura, K.; Ito, Y.; Ito, H.; Makiyama, K.; Uemura, H.
Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study. Diseases 2024, 12, 162.
https://doi.org/10.3390/diseases12070162
AMA Style
Yamaguchi K, Kawahara T, Hashizume A, Ousaka K, Uemura K, Ito Y, Ito H, Makiyama K, Uemura H.
Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study. Diseases. 2024; 12(7):162.
https://doi.org/10.3390/diseases12070162
Chicago/Turabian Style
Yamaguchi, Katsuya, Takashi Kawahara, Akihito Hashizume, Kimito Ousaka, Koichi Uemura, Yusuke Ito, Hiroki Ito, Kazuhide Makiyama, and Hiroji Uemura.
2024. "Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study" Diseases 12, no. 7: 162.
https://doi.org/10.3390/diseases12070162
APA Style
Yamaguchi, K., Kawahara, T., Hashizume, A., Ousaka, K., Uemura, K., Ito, Y., Ito, H., Makiyama, K., & Uemura, H.
(2024). Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study. Diseases, 12(7), 162.
https://doi.org/10.3390/diseases12070162